The latest industry happenings, all in one place.
Dr. Amie Smirthwaite
Science 37 announced that Mike Zaranek has joined the company as its chief financial officer.
Maetrics has appointed Dr. Amie Smirthwaite as Senior Director of the Global Clinical Practice.
Almac Group has welcomed confirmation from the EMA that, post-Brexit, Northern Ireland will remain in regulatory alignment with the EU, acknowledging that EU laws, in respect of medicinal products, shall continue to apply in Northern Ireland. The UK Government has now also confirmed that this will be the case.
Clinical Ink has implemented a study of a treatment for cytokine storm, the immunological reaction associated with severe cases of COVID-19, in just 15 business days.
Florence Healthcare is proud to name Melinda Rodriguez, Director of Regulatory Services at Elligo Health Research, as the winner of The Florence Effect initiative.
MedTech Breakthrough has announced that Perficient Inc. has been selected as the winner of the “Best Data Visualization Solution” award for its pharmacovigilance intelligence application, PV Hawk, in the fourth annual MedTech Breakthrough Awards program.
Tecentriq Falls Short in Phase III Trial in Post-Surgery Triple-Negative Breast Cancer Patients
February 6th 2025In the ALEXANDRA/IMpassion030 trial, Tecentriq (atezolizumab) added to postoperative chemotherapy was not found to improve treatment outcomes for patients with high-risk early-stage triple-negative breast cancer.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.